Voyageur Pharmaceuticals Ltd (TSX-V:VM, OTC:VYYRF) announced the appointment of Dr Ibrahim Hashmi as Vice President of Business Development to accelerate the company’s commercial initiatives and expand its global presence in the medical imaging industry.
According to Voyageur, Hashmi brings over 25 years of experience in leading high-performance business and medical teams across international markets, including Asia Pacific, the Middle East, Africa, and Central Asia.
He previously held roles at multinational corporations such as GE Healthcare and Amersham Health.
“Dr. Hashmi’s appointment marks a pivotal moment for Voyageur as we work to establish a stronger presence in the global medical imaging industry,” said Brent Willis, CEO of Voyageur Pharmaceuticals.
“His proven ability to develop commercial strategies and drive growth will be instrumental as we expand our product portfolio, cultivate partnerships, and strengthen our international market foothold.”
Hashmi is expected to help Voyageur scale its operations and introduce its sustainably sourced medical imaging contrast media products to new markets.
"I am honored to join Voyageur at such an exciting time in its growth trajectory," Hashmi said.
"The company’s vision of delivering cost-efficient, sustainable medical imaging solutions aligns with my own commitment to advancing healthcare. I look forward to working with the team to accelerate our growth and become a preferred partner in the imaging contrast media market."